Sulfated Casein Derivative from Canada
Sulfated casein derivative introduces sulfate groups for anticoagulant biomedical applications and cosmetics. Under HTS 3501.90.60.00 as other derivatives, it avoids chapter 30 medicaments via unfinished state. Supports heparin alternatives research.
Duty Rate — Canada → United States
60%
Rate breakdown
9903.03.1350%Articles the product of Canada as provided in subdivision (b)(2) of U.S. note 51 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Report sulfate content and bioactivity assays to distinguish from pharma intermediates
• Include biocompatibility ISO 10993 certs for device component imports
• Declare research vs commercial use to guide FDA pathway